Nifty seen touching 7,000 by end 2013: Goldman Sachs

Mon Jan 7, 2013 3:57pm IST

Investors watch a display at a local share market in Chandigarh December 18, 2008. REUTERS/Ajay Verma/Files

Investors watch a display at a local share market in Chandigarh December 18, 2008.

Credit: Reuters/Ajay Verma/Files

Related Topics

Stocks

   

Reuters Market Eye - Goldman Sachs maintains its "overweight" call on Indian stocks, with an end-2013 target for the Nifty of 7,000 points.

Goldman includes Bajaj Auto(BAJA.NS) and Tata Steel(TISC.NS) in its Asia-Pacific "growth recovery" group of stocks that have favourable growth and valuations, according to its Asia-Pacific outlook report dated Jan 4.

The bank sees Infosys as a stock with a potential "catch-up" opportunity after lagging in 2012.

Infosys shares fell 16.2 percent in 2012, widely under-performing the broader 27.7 percent gain in the Sensex.

Goldman also highlights Tata Motors, Sterlite Industries (India) Ltd STRL.NS and Hindalco Industries Ltd as stocks with favourable macro exposure and attractive profiles versus regional peers.

(Reporting by Manoj Dharra)

FILED UNDER:

Reuters Showcase

FMC-SEBI Merger

FMC-SEBI Merger

Regulatory shakeup could revive commodities markets   Full Article 

Market Eye

Market Eye

Sensex, Nifty end higher after bumpy budget-day trading  Full Article 

Tax Incentives

Tax Incentives

Budget woos foreign investors  Full Article 

Excise Duty

Excise Duty

Cigarette makers fall after budget hikes excise duty  Full Article 

Welcoming the Budget

Welcoming the Budget

India Inc cheers corporate tax cut, simpler rules  Full Article 

Gold Price

Gold Price

Gold prices to rise after budget keeps import duty high  Full Article 

Fuel Prices

Fuel Prices

IOC to raise diesel, petrol prices from Sunday  Full Article 

Moody's on Budget

Moody's on Budget

Budget "credit neutral" from a ratings perspective - Moody's   Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage